Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas

October 3, 2023 updated by: King's College Hospital NHS Trust

The Accuracy of Advanced Probabilistic Diffusion Tensor Tractography (DTT) for the Pre-operative Identification of Facial Nerve Position in Patients With Extrameatal Vestibular Schwannomas.

Vestibular schwannomas (VS) arise from the vestibulocochlear (hearing and balance) nerve, located at the base of the brain. Although benign, VS can enlarge over time, resulting in debilitating symptoms; therefore, surgical removal is frequently offered. One significant risk of surgery is inadvertent injury to the facial nerve, which lies adjacent to the vestibulocochlear nerve. Currently, the nerve's course is only revealed during surgical dissection and injury can cause permanent facial weakness. It would therefore be useful for the surgeon to know the course of the nerve before operating. To this end, a new MRI technique known as probabilistic diffusion tensor tractography (DTT) has shown potential in revealing the course of the facial nerve pre-operatively. However, its clinical reliability remains uncertain.

This study aims to investigate the reliability of DTT in identifying the course of the facial nerve preoperatively in patients undergoing surgery for VS.

The future benefit would be to enable surgeons to operate with more confidence and potentially reduce the chance of nerve injury.

The study will recruit adult patients due to have surgery for VS. The only change to the participants' clinical pathways will be the addition of a DTT sequence to their pre-operative MRI scans (increasing scanning time by approximately 10 minutes).

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

BACKGROUND AND RATIONALE Vestibular schwannomas (VS) are peripheral nerve sheath tumours arising from the vestibulocochlear nerve, which emerges from the brainstem at the base of the brain and enters the structures of the inner ear via a small bony canal within the skull (internal auditory meatus). VS account for 8% (Johnson J et al.) of intracranial tumours and, although benign, these tumours can grow resulting in several potentially debilitating symptoms, including hearing loss, vertigo, tinnitus, facial paralysis and meningitis. Furthermore, large tumours may cause compression on the brainstem, which can, in some cases, have life-threatening consequences (Johnson J et al.). Therefore, patients diagnosed with larger tumours (>1.5cm extrameatal component) are frequently offered surgical resection (as opposed to conservative management or stereotactic radiosurgery). As surgical techniques have improved, the goal of surgery has broadened to include not only tumour removal, but also preservation of the function of the nerves involved by VS. In particular, surgical resection aims to preserve the function of the facial nerve, responsible for innervating the muscles of facial expression, and which runs alongside the vestibulocochlear nerve and is frequently displaced and flattened by VS. Given its juxtaposition, the facial nerve is at high risk of injury during surgery. Injury to the facial nerve (and consequent debilitating facial weakness or paralysis) is a serious potential risk of vestibular schwannoma (VS) surgery. However, at present, the only means of avoiding nerve injury involves a combination of meticulous surgical technique and the use of a facial nerve monitor (a device that can detect activity within the facial muscles when stimulated by a surgeon-held probe); however, despite this, facial nerve injury may still occur. Indeed, until the surgeon begins operating, the course of the facial nerve is unknown. In a large series (>1000 surgical cases) by Sampath et al., the position of the facial nerve position was found most commonly on the anterior middle portion of the tumour; however, in a smaller proportion of cases, the nerve lay in 1 of 7 additional locations (Sampath et al.). Therefore, it follows that preoperative detection and identification of the course of the facial nerve would be extremely useful to guide surgery and reduce the potential risk of neuronal injury.

There now exists a potential means of non-invasively identifying the course of the facial nerve using advanced applications of magnetic resonance imaging (MRI). This involves utilising a technique known as diffusion tensor tractography (DTT), which has the capacity to detect the direction (vector) of diffusivity in a particular volume of tissue (voxel) (Mukherjee et al.). This data can be subsequently used to reveal structures, such as nerve fibre tracts, that are arranged along particular vectors, enabling them to be differentiated from surrounding tissue (Cauley et al.). This cannot be achieved using standard MRI sequences, in which the flattened nerve often becomes indistinguishable from the adjacent VS. Fortunately, as MRI represents the current means of diagnosing and characterising VS, adding an additional DTT sequence to a patient's scan does not represent a significant burden (only approximately 10 additional minutes of scanning time to acquire the DTT data).

Several groups (Choi et al., Taoka et al., Gerganov et al., Zhang et al. and Song et al.) have used DTT to delineate the course of the facial nerve in patients with VS and the majority have reported high success rates (>90% agreement with operative findings). However, many of these studies employed 'deterministic' DTT, which has drawbacks that limit its reliability in the setting of small fibre tracts with complex geometry. In particular, it is unable to accurately track fibres that cross, split or merge because the technique assumes that adjacent voxels have similar vectors. In order to overcome these limitations, we propose using the newer 'probabilistic' DTT technique that calculates a vector for each voxel analysed. It therefore has the capacity to account for complex geometries, such as those encountered in the facial nerve, particularly where its course is heavily distorted by tumour tissue. Zolal et al. used this technique in 21 patients with VS, resulting in an agreement rate of 81% for the position of the facial nerve and 33% for the cochlear nerve (Zolal et al.). However, there is an ongoing need for further studies in this area.

This project seeks to clarify the accuracy, reproducibility and practicality of probabilistic DTT in locating the facial nerve pre-operatively. If the technique proves accurate, it will potentially help with pre-operative planning and avoidance of facial nerve injury during VS surgery. Additionally the project seeks to clarify associated practical issues; in particular, the inter-observer/intra-observer variability (i.e. whether the reading radiologists agree with each other and themselves when analysing DTT images), whether the facial nerve position can be partially inferred on conventional sequences (comparing this with DTT) and whether adjacent nerves (such as the vestibulocochlear nerve) can be identified, which may further help with surgical preoperative planning.

HYPOTHESIS:

It is hypothesised that preoperative advanced probabilistic diffusion tensor tractography (DTT) will accurately demonstrate the position of the facial nerve relative to extrameatal portion of a vestibular schwannoma. It is proposed that the accuracy will be superior to previous studies in which deterministic DTT has been used to demonstrate the position of the facial nerve. This pre-operative mapping has the potential to decrease the rates of facial nerve injury during vestibular schwannoma surgery and allow for increased resection of the tumour.

STUDY DESIGN:

Prospective cohort observational study.

For study eligibility and outcome measures, please see the relevant sections.

IMAGE ANALYSIS

MRI In addition to standard imaging assessment, further image analysis will be performed offline using MRTrix 3.0 (www.mrtrix.org) in tensor probabililty mode. The presence of one or more cranial nerve tracts will be determined by their consistent depiction following their systematic interrogation with varying anisotropy thresholds. There will be a qualitative assessment of cranial nerve position will be achieved by dividing the circumference of the extrameatal vestibular schwannoma into segments.The assessment will be performed by two observers.

Reference standard:

The position of the facial nerve with respect to the extrameatal portion of the vestibular schwannoma will be assessed at surgery will be achieved by dividing the circumference of the extrameatal vestibular schwannoma into multiple segments in the same manner as above. This assessment will be made independently of the results of the pre-operative probabilistic DTT (the neurosurgeon recording the data will be blinded to the DTT findings).

STATISTICAL CONSIDERATIONS

Sample size calculation:

Power calculation based upon a sample size of 32, assuming a true kappa coefficient of 0.9; the 95% confidence interval will have a width of 0.26 (0.77 - 1.03). The number (32) also reflects the number of cases that we expect to recruit over a 2-3 year period.

Study Type

Interventional

Enrollment (Estimated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United Kingdom
      • London, United Kingdom, SE5 9RS
        • Recruiting
        • King's College Hospital NHS Foundation Trust
        • Contact:
        • Principal Investigator:
          • Steve Connor, FRCR
        • Principal Investigator:
          • Philip Touska, FRCR
        • Sub-Investigator:
          • Nick Thomas, FRCS
        • Sub-Investigator:
          • Dan Jiang, PhD FRCS
        • Sub-Investigator:
          • Rupert Obholzer, FRCS
        • Sub-Investigator:
          • Haris Shuaib
        • Sub-Investigator:
          • Sinan Al-Barazi, FRCS
        • Sub-Investigator:
          • Amanda Hitchings
        • Sub-Investigator:
          • Hayley Cheetham
        • Sub-Investigator:
          • Eleni Maratos, PhD FRCS
        • Sub-Investigator:
          • Jonathan Shapey, FRCS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • The capacity to understand the patient information sheet and the ability to provide written informed consent
  • >1.5cm extrameatal tumor determined to represent a vestibular schwannoma by preoperative imaging
  • HB grade I or II preoperatively

Exclusion Criteria:

  • Patients not meeting the above inclusion criteria
  • Standard contraindications to MRI
  • Previous cranial radiotherapy or previous surgery to the cerebellopontine angle cistern or IAM

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients having pre-operative DTT prior to surgery
All patients in this study will undergo DTT as part of a pre-operative MRI.
Diagnostic test: Probabilistic diffusion tensor tractography
Patients enrolled in this study will undergo probabilistic diffusion tensor tractography (additional MRI sequence) preoperatively in order to determine whether this it is possible to determine the course of the facial nerve.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy of probabilistic diffusion tensor tractography (DTT)
Time Frame: 4 years
To assess the accuracy of pre-operative probabilistic DTT in determining the position of the facial nerve (relative to extrameatal portion of a vestibular schwannoma) by using the facial nerve position at surgery as a reference standard.
4 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reproducibility
Time Frame: 4 years
To assess the interobserver and intraobserver reproducibility in the assessment of cranial nerve position on pre- operative probabilistic DTT images.
4 years
Relationship of tumour size with confidence
Time Frame: 4 years
To assess the relationship of tumour size with confidence when determining facial nerve position on pre-operative probabilistic DTT.
4 years
Relationship of tumour size with accuracy
Time Frame: 4 years
To assess the relationship of tumour size with accuracy when determining facial nerve position on pre-operative probabilistic DTT.
4 years
Facial nerve shape
Time Frame: 4 years
To compare the surgical assessment of facial nerve shape (compact or flat morphology, secondary to tumour-related pressure effects) with the ability to assess facial nerve position on pre-operative probabilistic DTT images.
4 years
Comparison of DTT with conventional anatomical sequence
Time Frame: 4 years
To compare the confidence and accuracy of pre-operative probabilistic DTT with high resolution T2w imaging (a standard anatomical MRI sequence obtained on routine pre-operative scanning) when determining facial nerve position.
4 years
Assessment of adjacent CPA nerves.
Time Frame: 4 years
To assess whether adjacent cranial nerves that lie at the cerebellopontine angle (base of the brain) and internal auditory meatus (inner ear canal) can be detected with pre-operative probabilistic DTT.
4 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

King's College Hospital NHS Trust

Collaborators

Guy's and St Thomas' NHS Foundation Trust

Investigators

  • Principal Investigator: Steve Connor, MBBS, FRCR, King's College Hospital NHS Trust

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 27, 2019

Primary Completion (Estimated)

June 28, 2024

Study Completion (Estimated)

June 28, 2024

Study Registration Dates

First Submitted

July 11, 2019

First Submitted That Met QC Criteria

August 13, 2019

First Posted (Actual)

August 15, 2019

Study Record Updates

Last Update Posted (Actual)

October 4, 2023

Last Update Submitted That Met QC Criteria

October 3, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 226479

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vestibular Schwannoma

Clinical Trials on Probabilistic diffusion tensor tractography

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe